The Motley Fool Discussion Boards

Previous Page

Investing/Strategies / New Paradigm Investing

URL:  http://boards.fool.com/i-think-what-missash-is-alluding-to-is-whether-or-25435012.aspx

Subject:  Re: What is to be gained........? Date:  4/26/2007  2:37 PM
Author:  twopairfullhouse Number:  30764 of 70983

I think what missash is alluding to is whether or not it's worth approving, if most are going to have negligible improvement in lifespan and/or quality of life. If the results are not spectacular, are we as a society willing to pay the large amounts necessary for the treatment? I say, 'we as a society', because we're all paying into Medicare. Are the treatments going to be worth the money? I think it's a valid question from someone who has been in the trenches.

However, I don't think the FDA should be doing too much along the lines of whether a particular drug is worth what the provider is charging. Their inquiry should be mainly confined to whether it is safe. Efficacy is what Scher and Hussain seem to be hung up on. If they're being honest here, I have no problem with their objection.

Dean
Copyright 1996-2014 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us